|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
|
5R01CA188523-05
|
$323,700
|
WALLER, EDMUND
|
EMORY UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S1
|
$629,550
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S2
|
$200,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S3
|
$125,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-11
|
$2,266,216
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Understanding and predicting relapse in acute myeloid leukemia
|
2R01CA175008-06
|
$418,000
|
RADICH, JERALD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$379,286
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Transplant Outcomes in Aplastic Anemia
|
ZIA CP010190 10508
|
$148,213
|
Gadalla, Shahinaz
|
DCEG (NCI)
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-34
|
$666,666
|
DAVIDSON, NANCY
|
UNIVERSITY OF WASHINGTON
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
3P30CA196521-04S1
|
$249,999
|
PARSONS, RAMON
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
3P30CA196521-04S2
|
$224,981
|
PARSONS, RAMON
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
5P30CA196521-04
|
$2,373,000
|
PARSONS, RAMON
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Role of Trisomy 21 in Hematopoiesis and Leukemogenesis
|
5F31CA196231-04
|
$31,044
|
LIGGETT, LUTHER
|
UNIVERSITY OF COLORADO DENVER
|
|
The role of intestinal microbiota in graft-versus-host disease
|
1R01CA228308-01
|
$525,957
|
VAN DEN BRINK, MARCEL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The role and functional mechanism of TET1 in MLL-rearranged leukemia
|
5R01CA178454-07
|
$369,725
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults receiving Hematopoietic Cell Transplantation
|
1R01CA225629-01
|
$524,411
|
ROSENBERG, ABBY
|
SEATTLE CHILDREN'S HOSPITAL
|
|
The impact of cell-specific deletion of MHC class I in generating glioma-specific T cell responses
|
1F31CA221336-01A1
|
$22,086
|
MALO, COURTNEY
|
MAYO CLINIC ROCHESTER
|
|
The impact of aging-associated chronic inflammation on the selection for oncogenic driver mutations in hematopoietic stem cells
|
5F30CA210383-03
|
$41,416
|
HIGA, KELLY
|
UNIVERSITY OF COLORADO DENVER
|
|
The contribution of the innate immune sensor STING in GVHD and GVL following allogeneic hematopoietic stem cell transplantation
|
1F31CA216999-01A1
|
$44,524
|
BADER, CAMERON
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Targeting novel DAMP mediated signaling pathways to mitigate GVHD
|
5R01CA217156-02
|
$429,228
|
REDDY, PAVAN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Targeting Granzyme B to Separate GVH from GVL Responses
|
5R01CA184728-05
|
$353,419
|
CAO, XUEFANG
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Targeting Cdc42 for bone marrow transplant therapies
|
5R01CA193350-04
|
$356,850
|
ZHENG, YI
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeted therapy of B cell malignances with CAR-T cells of defined composition
|
5R01CA136551-10
|
$560,424
|
RIDDELL, STANLEY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted Alpha Radioimmunotherapy with Haploidentical Bone Marrow Transplantation for AML
|
5K01CA188151-04
|
$169,020
|
OROZCO, JOHNNIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
T cell receptor proximal signaling
|
ZIA BC 011715
|
$596,931
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
T cell Development and Regeneration
|
ZIA BC 011633
|
$1,139,421
|
Bhandoola, Avinash
|
CCR (NCI)
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$366,567
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients
|
ZIA BC 010938
|
$479,461
|
Kong, Heidi
|
CCR (NCI)
|
|
Stem Cell-Adrenomedullin Therapy for Cancer Linked Lymphedema
|
5R21CA201940-03
|
$109,038
|
HU, MICKEY
|
PANORAMA RESEARCH, INC.
|
|
Stanford Cancer Institute
|
3P30CA124435-11S1
|
$248,520
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
SPORE in Myeloid Malignancies
|
5P50CA206963-02
|
$2,300,000
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Specialized Program Of Research Excellence (SPORE) in Leukemia.
|
2P50CA171963-06
|
$2,299,839
|
LINK, DANIEL
|
WASHINGTON UNIVERSITY
|
|
Specialized Program Of Research Excellence (SPORE) in Leukemia.
|
3P50CA171963-06S1
|
$66,323
|
LINK, DANIEL
|
WASHINGTON UNIVERSITY
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
5K08CA184552-05
|
$127,865
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
Programming T Cell Fates for Therapeutic Use
|
ZIA BC 011480
|
$827,168
|
Gattinoni, Luca
|
CCR (NCI)
|
|
Prevention of bone loss after pediatric hematopoietic cell transplantation
|
5R01CA181024-05
|
$477,235
|
SARAFOGLOU, KYRIAKIE
|
UNIVERSITY OF MINNESOTA
|
|
Preclinical development and clinical monitoring of adoptive immune therapy
|
ZIC BC 011029
|
$364,078
|
Rose, Jeremy
|
CCR (NCI)
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$374,676
|
Aplan, Peter
|
CCR (NCI)
|
|
Postmortem Pathology
|
ZIC BC 010685
|
$715,711
|
Kleiner, David
|
CCR (NCI)
|
|
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
|
ZIA BC 011214
|
$613,782
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
Pharmacoepidemiology and Cancer Risk
|
ZIA CP010144 10773
|
$27,379
|
Gadalla, Shahinaz
|
DCEG (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|